Discover
IFRX
InflaRx N.V.
2.33
2 x 1.75
2 x 2.85
bid
ask
+
0.09
4.02%
2 @ 04:00 PM
2.36 +0.03 (1.29%)
| Ytd | 130.69% | |
| 1y | 191.25% |
2.17
day range
2.49
0.74
52 week range
2.95
| Open | 2.24 | Prev Close | 2.24 | Low | 2.17 | High | 2.49 | Mkt Cap | 343.19M |
| Vol | 1.77M | Avg Vol | 2.01M | EPS | -0.72 | P/E | N/A | Forward P/E | -2.36 |
| Beta | 1.58 | Short Ratio | 5.17 | Inst. Own | 22.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 2.09 | 200-d Avg | 1.36 | 1yr Est | 8.09 |
IFRX News
benzinga.com
InflaRx Mulls Feasibility For AAV In Europe
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics b
globenewswire.com
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Followi
Jena, Germany, June 30, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical c